Big Pharma v Small Pharma for Medical Science Liaisons (MSLs)

Big Pharma v Small Pharma for Medical Science Liaisons (MSLs)

24 Minuten

Beschreibung

vor 2 Jahren

Join my free newsletter and join over 3000 other medical affairs
professionals getting insights on the MSL role In this episode I
interview Kirsten Gurtowsky MSL at Novartis.





We discuss:


Differences of an medical science liaison working in big
pharma versus small pharma

Advantages of both

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15